Standard Biotools (LAB) Total Debt (2010 - 2024)

Standard Biotools (LAB) has 7 years of Total Debt data on file, last reported at $54.9 million in Q3 2024.

• Quarterly Total Debt rose 471.12% year-over-year to $54.9 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $54.9 million (up 471.12% YoY) and the FY2023 annual result came in at $57.9 million, up 607.15% from the prior year.
• Total Debt held at $54.9 million in Q3 2024 per LAB's latest filing, from $54.8 million in the prior quarter.
• Across five years, Total Debt topped out at $57.9 million in Q4 2023 and bottomed at $8.2 million in Q4 2022.
• The 4-year median for Total Debt is $10.2 million (2022), against an average of $21.9 million.
• The widest annual swing landed in 2022, when Total Debt slumped 51.48%; it then jumped 607.15% in 2023.
• Tracing LAB's Total Debt over 4 years: stood at $16.9 million in 2021, then tumbled by 51.48% to $8.2 million in 2022, then jumped by 607.15% to $57.9 million in 2023, then slipped by 5.23% to $54.9 million in 2024.
• Per Business Quant, the three latest LAB Total Debt figures stand at $54.9 million (Q3 2024), $54.8 million (Q2 2024), and $57.9 million (Q4 2023).

Peer Comparison